Immune cell labelling and tracking: implications for adoptive cell transfer therapies
Abstract Background The understanding of the role of different immune cell subsets that infiltrate tumors can help researchers in developing new targeted immunotherapies to reactivate or reprogram them against cancer. In addition to conventional drugs, new cell-based therapies, like adoptive cell tr...
Main Authors: | Filippo Galli, Michela Varani, Chiara Lauri, Guido Gentiloni Silveri, Livia Onofrio, Alberto Signore |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2021-02-01
|
Series: | EJNMMI Radiopharmacy and Chemistry |
Subjects: | |
Online Access: | https://doi.org/10.1186/s41181-020-00116-7 |
Similar Items
-
Adoptive T Cell Immunotherapy for Cancer
by: Karlo Perica, et al.
Published: (2015-01-01) -
NIVO-TIL: combination anti-PD-1 therapy and adoptive T-cell transfer in untreated metastatic melanoma: an exploratory open-label phase I trial
by: Jean-Matthieu L'Orphelin, et al.
Published: (2024-11-01) -
New Orders to an Old Soldier: Optimizing NK Cells for Adoptive Immunotherapy in Hematology
by: Mehmet Gunduz, et al.
Published: (2021-09-01) -
Clinical scale rapid expansion of lymphocytes for adoptive cell transfer therapy in the WAVE<sup>® </sup>bioreactor
by: Somerville Robert PT, et al.
Published: (2012-04-01) -
Recent Advances in the Development of Bioreactors for Manufacturing of Adoptive Cell Immunotherapies
by: Irina Ganeeva, et al.
Published: (2022-12-01)